drugset / Trial / NCT05545319
A Study to Learn About the Medicine Called Nirmatrelvir Used in Combination With Ritonavir in People With Weakened Immune Systems or at Increased Risk for Poor Outcomes Who Are Hospitalized Due to Severe COVID-19
RandomizedParallel-groupQuadruple-blindTreatment
Summary
A Study to Learn About the Medicine Called Nirmatrelvir Used in Combination With Ritonavir in People with Weakened Immune Systems or at Increased Risk for Poor Outcomes who are Hospitalized Due to Severe COVID-19
Timeline
- Start
- 2022-12-13
- Primary completion
- 2023-09-21
- Completion
- 2024-01-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Nirmatrelvir | Small molecule | 150 mg | Oral |
| Subject | Nirmatrelvir | Small molecule | 300 mg | Oral |
| Background | Ritonavir | Other / unclassified | 100 mg | Oral |